Nouhad Husseini

Director/Board Member at DECIBEL THERAPEUTICS, INC.

Health Technology

Consumer Services

Profile

Nouhad Husseini is currently the Director & Managing Director at Checkmate Pharmaceuticals, Inc. and Decibel Therapeutics, Inc. He also holds the position of Senior VP-Business Development at Regeneron Pharmaceuticals, Inc. Husseini completed his undergraduate degree at Princeton University and obtained an MBA from The Wharton School of the University of Pennsylvania.

Nouhad Husseini active positions

Companies	Position	Start
REGENERON PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/01/2011
CHECKMATE PHARMACEUTICALS, INC.	Director/Board Member	31/05/2022
DECIBEL THERAPEUTICS, INC.	Director/Board Member	22/09/2023

All active positions of Nouhad Husseini

Training of Nouhad Husseini

Princeton University	Undergraduate Degree
The Wharton School of the University of Pennsylvania	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Nouhad Husseini's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
REGENERON PHARMACEUTICALS, INC.	Health Technology
DECIBEL THERAPEUTICS, INC.	Health Technology

Private companies	1
Checkmate Pharmaceuticals, Inc. Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA.	Health Technology